Policy & Regulation
12 July 2024 - Swedish research-based biopharma company BioArctic AB (STO:BIOA-B) and its partner Eisai Co Ltd (TYO:4523) announced on Friday the approval of Leqembi (lecanemab) for Alzheimer's d...
12 July 2024 - Clinical stage biotechnology company Biosergen AB (STO:BIOSGN) announced on Friday the dosing of the first patient with BSG005 for invasive fungal infection rescue therapy.In collaborat...
12 July 2024 - Kolon TissueGene, Inc., an advanced cell therapies company, announced on Thursday that it has completed its US phase three clinical trials for Knee Osteoarthritis.The company has comple...
12 July 2024 - YolTech Therapeutics, a biotech company, announced on Thursday that it has enrolled its first subject in a phase one clinical trial of YOLT-201, the company's independently develop...
12 July 2024 - Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company, announced on Thursday that it has named Henry Pelish, PhD as its new chief scientific officer.In the new role,...
12 July 2024 - CureLab Oncology, a clinical-stage biotech company, announced on Thursday that it has named Dr Aubrey C Galloway as its new chief medical officer (CMO).In the new role, Dr Galloway will...